EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

NEW YORK, April 16, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

http://www.reportlinker.com/p02063638/EpiCast-Report-Allergic-Rhinitis---Epidemiology-Forecast-to-2023.html

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

Summary

Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and sore throat. Research suggests that a combination of genetic factors such as family history of allergic rhinitis and environmental factors such as exposure to allergens, including smoke, dust, pollen, insects, molds, or animal dander, may increase the risk for developing allergic rhinitis. According to the World Health Organization, an estimated 400 million people worldwide were affected with allergic rhinitis during 1996–2006.

According to GlobalData's epidemiological forecast, the total prevalent cases of allergic rhinitis in the 7MM will increase from 123,273,876 total prevalent cases in 2013 to 125,427,387 total prevalent cases in 2023, at an annual growth rate (AGR) of 0.17% during the forecast period. In 2023, the US will have the highest number of the total prevalent cases of allergic rhinitis with 39,031,365 total prevalent cases, followed by Japan with 36,602,227 total prevalent cases.

To forecast the total prevalent cases of allergic rhinitis in the 7MM, GlobalData epidemiologists selected nationally representative studies that provided total prevalence of allergic rhinitis using uniform diagnostic criteria based on the self-reported prevalence of allergic rhinitis. The use of studies that provided uniform diagnostic criteria for total prevalence of allergic rhinitis facilitated meaningful comparison of the forecast total prevalent cases of allergic rhinitis across the 7MM. Additionally, GlobalData epidemiologists provide the total prevalent cases of allergic rhinitis segmented by the etiological type of allergic rhinitis (seasonal, perennial, and both), as well as by the severity of allergic rhinitis (mild, moderate, and severe) in these markets. In addition, GlobalData epidemiologists provide the population of allergic rhinitis cases segmented by sensitization to specific allergens in the six major markets (6MM) (France, Germany, Italy, Spain, UK and Japan), which are of utmost importance in the management of the condition.

Scope

- The Allergic Rhinitis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends of allergic rhinitis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the total prevalent cases of allergic rhinitis segmented by sex and age (ages =18 years).
- The allergic rhinitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global allergic rhinitis market.
- Quantify patient populations in the global allergic rhinitis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for allergic rhinitis therapeutics in each of the markets covered.
1 Table of Contents
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.2.1 Family history of allergic rhinitis is a strong predictor for allergic rhinitis in children and adults 11
3.2.2 Exposure to allergens in the environment increases the risk for allergic rhinitis 12
3.2.3 Urban living elevates the risk of allergic rhinitis 13
3.2.4 People with allergic rhinitis suffer from several comorbidities 13
3.3 Global and Historical Trends 15
3.3.1 US 15
3.3.2 5EU 16
3.3.3 Japan 17
3.4 Forecast Methodology 18
3.4.1 Sources Used 20
3.4.2 Sources Not Used 23
3.4.3 Forecast Assumptions and Methods 24
3.5 Epidemiological Forecast of Allergic Rhinitis (2013-2023) 28
3.5.1 Total Prevalent Cases of Allergic Rhinitis 28
3.5.2 Age-Specific Total Prevalent Cases of Allergic Rhinitis 29
3.5.3 Sex-Specific Total Prevalent Cases of Allergic Rhinitis 31
3.5.4 Age-Standardized Total Prevalence of Allergic Rhinitis 33
3.5.5 Distribution of Total Prevalent Cases of Allergic Rhinitis by Severity 34
3.5.6 Distribution of Total Prevalent Cases of Allergic Rhinitis by Type 35
3.5.7 Allergic Rhinitis Total Prevalent Cases Sensitized to Specific Allergens 36
3.6 Discussion 37
3.6.1 Epidemiological Forecast Insight 37
3.6.2 Limitations of the Analysis 38
3.6.3 Strengths of the Analysis 39
4 Appendix 40
4.1 Bibliography 40
4.2 About the Authors 44
4.2.1 Epidemiologists 44
4.2.2 Reviewers 44
4.2.3 Global Director of Epidemiology and Health Policy 46
4.2.4 Global Head of Healthcare 46
4.3 About GlobalData 47
4.4 About EpiCast 47
4.5 Disclaimer 48

1.1 List of Tables

Table 1: Classification of Allergic Rhinitis 10
Table 2: Risk Factors and Comorbidities for Allergic Rhinitis 11
Table 3: Prevalence of Most Frequently Occurring Comorbidities in People with Allergic Rhinitis 14
Table 4: Age-Specific Prevalence of Hay Fever from the NHIS Survey in 2011 16
Table 5: Age- and Sex-Standardized Self-Reported Total Prevalence (%) of Allergic Rhinitis, Ages 20-44 Years, 5EU 17
Table 6: Total Prevalence(%) of Allergic Rhinitis in the 4EU, Ages 6-14 Years 17
Table 7: 7MM, Sources of Data Used for the Total Prevalence and the Segmentations for Allergic Rhinitis 19
Table 8: 7MM, Sources Excluded for the Epidemiological Forecast of Total Prevalent Cases of Allergic Rhinitis 24
Table 9: 7MM, Total Prevalent Cases of Allergic Rhinitis, Both Sexes, Ages ?18 Years, N, 2013 - 2023 28
Table 10: 7MM, Age-Specific Total Prevalent Cases of Allergic Rhinitis, Both Sexes, N (Row %), 2013 30
Table 11: 7MM, Sex-Specific Total Prevalent Cases of Allergic Rhinitis, Ages ?18 Years, N (Row %), 2013 32
Table 12: 7MM, Distribution of Total Prevalent Cases of Allergic Rhinitis by Severity, Both Sexes, N (Row %), 2013 35
Table 13: 7MM, Distribution of Total Prevalent Cases of Allergic Rhinitis by Type, Both Sexes, N (Row %), 2013 36
Table 14: 7MM, Proportion of Allergic Rhinitis Total Prevalent Cases Sensitized to Specific Allergens, Both Sexes, %, 2013 37

1.2 List of Figures

Figure 1: 7MM, Total Prevalent Cases of Allergic Rhinitis, Both Sexes, Ages ?18 Years, N, 2013-2023 29
Figure 2:7MM, Age-Specific Total Prevalent Cases of Allergic Rhinitis, Both Sexes, N, 2013 31
Figure 3: 7MM, Sex-Specific Total Prevalent Cases of Allergic Rhinitis, Ages ?18 Years, N, 2013 32
Figure 4: 7MM, Age-Standardized Total Prevalence (%) of Allergic Rhinitis, Ages ?18 Years, by Sex, 2013 34


To order this report: EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023
http://www.reportlinker.com/p02063638/EpiCast-Report-Allergic-Rhinitis---Epidemiology-Forecast-to-2023.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker